Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Gemina Laboratories Ltd (CSE:GLAB)

0.8100 UNCHANGED
Last Price Updated: 3:54 PM EDT, Jun 16, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Gemina Laboratories Ltd

< Previous 1 2 Next >
Gemina Announces Filing of Prospectus Supplement
VANCOUVER, BC / ACCESSWIRE / June 24, 2022 / Gemina Laboratories Ltd. (the "Company" or "Gemina") (CSE:GLAB)(FRA:8I7) is pleased to announce that the Company has entered into an agency agreement dated... 
From Gemina Laboratories Ltd.
Via AccessWire
Gemina Announces Proposed Financing Up to $5 Million
VANCOUVER, BC / ACCESSWIRE / June 21, 2022 / Gemina Laboratories Ltd. (the "Company" or "Gemina") (CSE:GLAB) (FRA:8I7) is pleased to announce that the Company has engaged Leede Jones Gable Inc., as... 
From Gemina Laboratories Ltd.
Via AccessWire
Gemina Labs Appoints Point-of-Care Diagnostic Executive Brian Firth as Advisor
VANCOUVER, BC / ACCESSWIRE / June 8, 2022 / Gemina Laboratories Ltd. (CSE:GLAB)(FRA:8I7) (the "Company" or "Gemina") is pleased to announce the appointment of Brian Firth as an adviser to the Company. 
From Gemina Laboratories Ltd.
Via AccessWire
Gemina Labs Announces CE Mark for its First Product - The Best in Class Legio-X COVID Rapid Antigen Test
- Less than two weeks after announcing the highly successful completion of human trials, Gemina has secured a European Union ("EU") CE Mark, which accelerates commercialization of the breakthrough... 
From Gemina Laboratories Ltd.
Via AccessWire
Gemina Labs Completes Successful Human Clinical Performance Evaluation on its Legio X COVID-19 Rapid Antigen Test
Our newswire features a comprehensive, flat-fee Press Release service. Generate quality engagement with real-time analytics to improve visibility and expand your influence. 
From Gemina Laboratories Ltd.
Via AccessWire
Gemina Labs Nears Completion of Phase 2 Human Patient Testing for Initial Diagnostic Test
Our newswire features a comprehensive, flat-fee Press Release service. Generate quality engagement with real-time analytics to improve visibility and expand your influence. 
From Gemina Laboratories Ltd.
Via AccessWire
Gemina Labs Provides Technical Development Update for Initial Diagnostic Test and Reports Filing of New IP
VANCOUVER, BC / ACCESSWIRE / March 31, 2022 / Gemina Laboratories Ltd. (CSE:GLAB)(FRA:8I7) (the "Company" or "Gemina") is pleased to provide recent development updates for its initial diagnostic test... 
From Gemina Laboratories Ltd.
Via AccessWire
Gemina Labs Establishes UK Subsidiary And Appoints David Browning As Head Of Productization
VANCOUVER, BC / ACCESSWIRE / February 23, 2022 / Gemina Laboratories Ltd. (CSE:GLAB)(FRA:8I7) (the "Company" or "Gemina") is pleased to announce the formation of a wholly owned UK Subsidiary, Gemina... 
From Gemina Laboratories Ltd.
Via AccessWire
Gemina Labs Strategic Update: From Product to Platform, Gemina Provides a Technology Roadmap
VANCOUVER, BC / ACCESSWIRE / February 15, 2022 / Gemina Laboratories Ltd. (CSE:GLAB)(FRA:8I7) (the "Company" or "Gemina") is pleased to provide the following strategic overview and share an outlook for... 
From Gemina Laboratories Ltd.
Via AccessWire
Gemina Labs Announces Completion of Significant Development Step for its SARS-CoV-2 Rapid Test
VANCOUVER, BC / ACCESSWIRE / February 3, 2022 / Gemina Laboratories Ltd. (CSE:GLAB)(FRA:8I7) (the "Company" or "Gemina") is pleased to provide an update on its current activities related to the... 
From Gemina Laboratories Ltd.
Via AccessWire
Gemina Labs Announces Appointment Of Senior Scientific Adviser
VANCOUVER, BC / ACCESSWIRE / November 18, 2021 / Gemina Laboratories Ltd. (CSE:GLAB)(FRA:8I7) (the "Company" or "Gemina") is pleased to announce the appointment of Professor Michael Catt as Senior... 
From Gemina Laboratories Ltd.
Via AccessWire
Gemina Labs Announces Closing of Oversubscribed Private Placement
VANCOUVER, BC / ACCESSWIRE / October 25, 2021 / Gemina Laboratories Ltd. (CSE:GLAB)(FRA:8I7) (the "Company" or "Gemina") is pleased to announce the closing of its previously announced CAD$2,000,000... 
From Gemina Laboratories Ltd.
Via AccessWire
Gemina Labs Announces Private Placement
VANCOUVER, BC / ACCESSWIRE / October 20, 2021 / Gemina Laboratories Ltd. (CSE:GLAB)(FRA:8I7) (the "Company" or "Gemina") is pleased to announce a non-brokered private placement offering (the... 
From Gemina Laboratories Ltd.
Via AccessWire
Gemina Labs Receives Positive Initial Manufacturing Results for SARS-CoV-2 Diagnostic Test
VANCOUVER, BC / ACCESSWIRE / September 20, 2021 / Gemina Laboratories Ltd. (CSE:GLAB)(FRA:8I7) (the "Company" or "Gemina") is pleased to provide an update on its current activities related to the... 
From Gemina Laboratories Ltd.
Via AccessWire
Gemina Labs Provides Research and Development and Corporate Update
VANCOUVER, BC / ACCESSWIRE / September 13, 2021 / Gemina Laboratories Ltd. (CSE:GLAB)(FRA:8I7) (the "Company" or "Gemina") is pleased to provide an update on its research and development ("R&D")... 
From Gemina Laboratories Ltd.
Via AccessWire
Gemina Labs Announces Research and Development Appointments
VANCOUVER, BC / ACCESSWIRE / August 30, 2021 / Gemina Laboratories Ltd. (CSE:GLAB) (the "Company" or "Gemina") is pleased to announce several key hires within our Research and Development team.... 
From Gemina Laboratories Ltd.
Via AccessWire
Gemina Labs Announces Listing on the Canadian Securities Exchange
VANCOUVER, BC / ACCESSWIRE / August 10, 2021 / Gemina Laboratories Ltd. (CSE:GLAB) (the "Company" or "Gemina") is pleased to announce that the common shares of the Company have begun trading on the... 
From Gemina Laboratories Ltd.
Via AccessWire
< Previous 1 2 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.